Answers are grounded in this paper and cite their sources.
A challenge in cancer therapy has been to identify targets whose function is essential for survival of malignant cells but not normal cells. This Perspective discusses recent evidence that novel inhibitors of the kinase TOR can provide an unprecedented balance of anti-cancer efficacy and tolerability.
No takes yet. Share an insight, caveat, or question.
Matthew R. Janes (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: